Yes, substances can move out of Group 3 as new data emerges. If subsequent research provides substantial evidence, the IARC may reclassify the agent into a category with a higher or lower carcinogenic risk. This emphasizes the dynamic nature of scientific inquiry where continuous research and technological advancements contribute to our understanding of cancer risks.
